Buchumschlag

Outcomes of relapsed favorable‐histology Wilms tumor in non‐clinical trial setting

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Netta Schneller, Najat Daw, Whitney Throckmorton, Elizabeth Mullen, Kylene DeSmith, Leo Mascarenhas, Cameron O'Connell, Conrad V. Fernandez, Kathryn S. Sutton, Rajkumar Venkatramani
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	Pediatric Blood & Cancer
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Alpha‐emitter therapy for pediatric relapsed metastatic pancreatic neuroendocrine tumor
von: Andrew Wahba, et al.
Veröffentlicht: (2024)

Lung relapse pattern in children with metastatic Wilms tumor
von: Giulia Fichera, et al.
Veröffentlicht: (2024)

Event‐free survival in relapsed and refractory rhabdomyosarcoma treated on cooperative group phase II trials: A report from the Children's Oncology Group
von: Jonathan Metts, et al.
Veröffentlicht: (2024)

Rhabdoid Tumor of the Kidney and Soft Tissues: Results from National Wilms Tumor Study‐5 and Children's Oncology Group Study AREN0321
von: James I. Geller, et al.
Veröffentlicht: (2024)

Concomitant Wilms tumor and autosomal dominant polycystic kidney disease
von: Andrew M. Fleming, et al.
Veröffentlicht: (2024)

Adolescents and young adults with rhabdomyosarcoma: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group
von: Douglas J. Harrison, et al.
Veröffentlicht: (2024)

An assessment of narrative operative reports for Wilms tumor resection using consensus component criteria
von: Zachary D. Morrison, et al.
Veröffentlicht: (2024)

Remaining Challenges in the Treatment of Relapsed Wilms Tumor: Children's Oncology Group and International Society of Paediatric Oncology Perspectives
von: Kathryn S. Sutton, et al.
Veröffentlicht: (2025)

Prevention of treatment abandonment remains an important challenge to increase survival of Wilms tumor in sub‐Saharan Africa: A report from Wilms Africa—CANCaRe Africa
von: Barnabas Atwiine, et al.
Veröffentlicht: (2024)

Anti‐Tumor Activity of Paclitaxel‐Containing Regimens in Recurrent/Refractory Wilms Tumor
von: Alissa Groisser, et al.
Veröffentlicht: (2025)

Comment on: Prognostic impact of pre‐referral tumor resection in unilateral Wilms tumor: A single‐institute experience from a lower middle‐income country
von: Shan Song
Veröffentlicht: (2024)

Children and young adults with newly diagnosed rhabdomyosarcoma metastatic to bone treated on Children's Oncology Group studies
von: Nathan J. Schloemer, et al.
Veröffentlicht: (2024)

Outcomes for patients with perineal and perianal rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee
von: Roshni Dasgupta, et al.
Veröffentlicht: (2024)

Retrospective experience of children with relapsed brain tumors treated with oral combination of axitinib and metronomic etoposide
von: Caroline Donzé, et al.
Veröffentlicht: (2024)

Reflections on 20 years of the Wilms Africa project: Lessons learned and the way forward
von: Trijn Israels, et al.
Veröffentlicht: (2024)

Late Events Occurring After 5 Years in Pediatric Rhabdomyosarcoma: A Report From the Children's Oncology Group
von: Sara Kreimer, et al.
Veröffentlicht: (2024)

Impact of Hospital Volume on Survival for Pediatric Wilms Tumor
von: Charbel Chidiac, et al.
Veröffentlicht: (2025)

Correction to “Omission of adjuvant chemotherapy in patients with completely necrotic Wilms tumor stage I and radiotherapy in stage III: The 30‐year SIOP‐RTSG experience.”
Veröffentlicht: (2024)

Wilms tumor characteristics, surgical management, outcomes, and chronic kidney disease in children with WAGR syndrome: A report from the International WAGR Syndrome Association survey
von: Elisabeth T. Tracy, et al.
Veröffentlicht: (2024)

Surgical aspects and outcomes after nephrectomy for Wilms tumour in sub‐Saharan Africa: A report from Wilms Africa Phase II—CANCaRe Africa
von: William Appeadu‐Mensah, et al.
Veröffentlicht: (2024)

Intermediate Risk Rhabdomyosarcoma in Very Young Children (Less Than or Equal to 24 Months) Treated on the Prior Children's Oncology Group Protocol ARST1431
von: Katrina Winsnes, et al.
Veröffentlicht: (2026)

A Rare Intersection: Wilms Tumor in a Patient with PIGO Syndrome
von: Şefika Akyol, et al.
Veröffentlicht: (2025)

Alveolar Soft Part Sarcoma in Pediatric and Young Adult Patients: A Report From the Children's Oncology Group Study ARST0332
von: Jacquelyn N. Crane, et al.
Veröffentlicht: (2026)

The accuracy of estimating equations for the evaluation of kidney function in adult survivors of unilateral, nonmetastatic, non‐syndromic Wilms tumor: A pilot study from the St. Jude Lifetime Cohort Study
von: Daniel M. Green, et al.
Veröffentlicht: (2024)

The Fate (Outcome) of Clinically Apparent Single Lesion and Oligofocal Nephroblastomatosis Treated According to SIOP/GPOH Protocols for Wilms Tumor
von: Nils Welter, et al.
Veröffentlicht: (2026)

A Rare Case of FANCC ‐Mutated Fanconi Anaemia Presenting With a Negative Chromosome Breakage Test
von: Mohsin Badat, et al.
Veröffentlicht: (2026)

Correction to “Outcomes of Relapsed Favorable‐Histology Wilms Tumor in Non‐Clinical Trial Setting”
Veröffentlicht: (2025)

Chronic spontaneous urticaria as the presenting feature in a paediatric case of chronic myeloid leukaemia
von: Kathryn M. Sutton, et al.
Veröffentlicht: (2024)

Time Toxicity in Wilms Tumor: Quantifying the Burden of Healthcare Interaction in the First Year After Diagnosis
von: Caleb Q. Ashbrook, et al.
Veröffentlicht: (2026)

Nephron‐Sparing Surgery for Patients With Wilms Tumor, a Surgical Delphi Study Consensus Statement
von: Matthijs Fitski, et al.
Veröffentlicht: (2025)

Nonorbital, Nonparameningeal Head and Neck Rhabdomyosarcoma: A Report From the Children's Oncology Group
von: Jamie M. Aye, et al.
Veröffentlicht: (2025)

Long‐term outcomes among survivors of childhood osteosarcoma: A report from the Childhood Cancer Survivor Study (CCSS)
von: Kerri Becktell, et al.
Veröffentlicht: (2024)

Multicenter Retrospective Analysis of Pediatric Differentiated Thyroid Carcinoma: Treatment Practices and Outcomes Prior to Pediatric American Thyroid Association Guidelines Implementation
von: Priya Mahajan, et al.
Veröffentlicht: (2025)

Pazopanib Combined With Vincristine and Irinotecan in Relapsed Wilms Tumor: Encouraging Outcomes in a Heavily Pretreated Pediatric Cohort
von: Maria Debora De Pasquale, et al.
Veröffentlicht: (2026)

Renal Parenchyma Preservation in a Child With Giant Bilateral Wilms Tumors Following SIOP‐Based Multistage Therapy
von: Ramin Malikov, et al.
Veröffentlicht: (2025)

Associations between Medicaid enrollment and diagnosis stage and survival among pediatric cancer patients
von: Kimberly J. Johnson, et al.
Veröffentlicht: (2024)

Synchronous B‐Cell Precursor Acute Lymphoblastic Leukaemia and Wilms Tumour in a Patient With Lateralised Overgrowth: Causation or Coincidence?
von: Karolina Miarka‐Walczyk, et al.
Veröffentlicht: (2025)

Adherence to Protocol Recommendations for Children With Wilms Tumour in Two Consecutive Studies in the United Kingdom and Ireland—Does Variation Matter?
von: Suzanne Tugnait, et al.
Veröffentlicht: (2026)

PD‐L1 Expression is Mediated by microRNA Processing, Wnt/β‐Catenin Signaling, and Chemotherapy in Wilms Tumor
von: Patricia D. B. Tiburcio, et al.
Veröffentlicht: (2025)

The Clinical Impact of Somatic Copy Number Variations in Patients With Stage IV Wilms Tumor Enrolled in the SIOP 2001 Trial and Study
von: Nils Welter, et al.
Veröffentlicht: (2025)